A comparative crossover study of two long-acting bronchodilator preparations
- 1 January 1976
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 4 (3) , 207-211
- https://doi.org/10.1185/03007997609109304
Abstract
A comparative crossover investigation was carried out in 18 patients with reversible airways obstruction to assess the bronchodilator effectiveness of aminophylline and salbutamol in long-acting tablet form. Patients received treatment for 4 weeks with either salbutamol 8 mg tablets in a dose of 2 tablets b.d. or aminophylline 225 mg tablets in a dose of 1 tablet b.d. increasing to 2 tablets b.d. after 1 week. They were then crossed over to the alternative preparation for a further 4 weeks. Peak expiratory flow rates (PEF) were measured at weekly intervals. Results showed that the aminophylline tablets produced a highly significant (p < 0.002) improvement in PEF values compared with salbutamol tablets when both treatment periods were considered, and patients considered they obtained longer lasting relief with the aminophylline preparation.Keywords
This publication has 3 references indexed in Scilit:
- A Trial of Phyllocontin (Slow Aminophylline) Tablets in Patients with BronchospasmJournal of International Medical Research, 1975
- A Continuous Release Aminophylline Tablet (Phyllocontin) in Patients with Airways ObstructionJournal of International Medical Research, 1975
- Human pharmacological and clinical studies on salbutamol: A specific β-adrenergic bronchodilatorRespiratory Medicine, 1969